Business Insider
My Markets Watchlist
Markets Stocks

Xylem Inc. Stock , XYL

128.14 +1.46 +1.16%
02:05:59 PM BTT
News Analyst Data Analyst Opinions Insider Activity Dividend Calendar

On Monday morning 06/09/2025 the Xylem Inc. share started trading at the price of $126.95. Compared to the closing price on Friday 06/06/2025 on BTT of $126.68, this is a gain of 0.22%. There are 243.35 M shares outstanding in Xylem Inc., which values the company at $25.28 B.
Is Xylem stock a Buy, Sell or Hold? Xylem stock has received a consensus rating of buy. The average rating score is and is based on 26 buy ratings, 7 hold ratings, and 0 sell ratings.
What was the 52-week low for Xylem stock? The low in the last 52 weeks of Xylem stock was 100.64. According to the current price, Xylem is 127.33% away from the 52-week low.
What was the 52-week high for Xylem stock? The high in the last 52 weeks of Xylem stock was 143.55. According to the current price, Xylem is 89.27% away from the 52-week high.
What are analysts forecasts for Xylem stock? The 33 analysts offering price forecasts for Xylem have a median target of 138.33, with a high estimate of 170.00 and a low estimate of 101.00. The median estimate represents a 92.63 difference from the last price of 128.14.

Xylem Stock Snapshot

128.13
Bid
70.00
Bid Size
128.20
Ask
11.00
Ask Size
6/9/2025
Date
2:05 PM
Time
20,440.00
Volume
126.68
Prev. Close
126.95
Open
30.83 B
Market Cap in USD
243.35 M
Number of Shares
243.35 M
Total Number of Shares
126.69
Day Low
128.40
Day High
128.14
100.64
52 Week Low
143.55
52 Week High
128.14
1.44
Dividend in USD
1.24
Dividend Yield
31.75
P/E Ratio
99.36
Free Float in %
3.65
EPS in USD
43.80
Book Value per Share in USD
5.19
Cash Flow per Share in USD

Historical Prices for Xylem

Loading..
Date Open Close Daily High Daily Low
Price change over selected period: 0% 0

Xylem Analyst Data

Total Analysts: 33
Buy Ratings: 26 Neutral Ratings: 7 Sell Ratings: 0
Analyst: {{ANALYST_DATA}}
Price-Target: {{PRICE_DATA}}
Rating: {{RATING_DATA}}
Price *Price Target
Lowest: 101.00 Median: 138.33 Highest: 170.00
*The average price target includes all analyst analysis, not just the most recent analysis presented in the chart.

Xylem Analyst Opinions

  • All
  • Buy
  • Hold
  • Sell
Date Analyst Rating Price
05/30/25 J.P. Morgan
Maintained Buy $148
04/30/25 RBC Capital Markets
Maintained Buy $147
04/30/25 Stifel, Nicolaus & Co., Inc.
Maintained Buy $141
04/30/25 Baird Patrick & Co
Maintained Buy $146
04/16/25 Stifel, Nicolaus & Co., Inc.
Maintained Buy $140
04/14/25 Citigroup Corp.
Maintained Buy $134
02/05/25 Baird Patrick & Co
Maintained Buy $148
01/24/25 Stifel, Nicolaus & Co., Inc.
Maintained Buy $150
07/18/24 Stifel, Nicolaus & Co., Inc.
Maintained Buy $170
05/31/24 Oppenheimer & Co. Inc.
Maintained Buy $152
05/29/24 Argus Research Company
Maintained Buy $165
05/03/24 RBC Capital Markets
Maintained Buy $162
05/03/24 Oppenheimer & Co. Inc.
Maintained Buy $147
05/03/24 Mizuho
Maintained Hold $135
05/03/24 Baird Patrick & Co
Maintained Buy $155
04/18/24 Oppenheimer & Co. Inc.
Maintained Buy $142
04/08/24 Citigroup Corp.
Maintained Hold $139
03/21/24 Baird Patrick & Co
Maintained Buy $148
03/12/24 Exane BNP Paribas
Maintained Buy $150
02/07/24 Citigroup Corp.
Maintained Hold $126
02/07/24 RBC Capital Markets
Maintained Buy $145
02/07/24 Stifel, Nicolaus & Co., Inc.
Maintained Buy $150
01/04/24 RBC Capital Markets
Maintained Buy $140
12/19/23 Stifel, Nicolaus & Co., Inc.
Maintained Buy $136
12/13/23 Wolfe Research
Maintained Buy $127
12/11/23 Citigroup Corp.
Maintained Hold $109
11/21/23 Deutsche Bank
Upgraded to Buy $120
11/01/23 Citigroup Corp.
Maintained Hold $104
11/01/23 RBC Capital Markets
Maintained Buy $120
10/19/23 Oppenheimer & Co. Inc.
Upgraded to Buy $118
10/09/23 Citigroup Corp.
Maintained Hold $101
08/29/23 Seaport Global Securities
Maintained Hold
08/03/23 RBC Capital Markets
Maintained Buy $129
06/29/23 Deutsche Bank
Maintained Hold $121

Xylem Estimates* in USD

  2025 2026 2027 2028
Revenue 8,752 9,172 9,674 10,143
Dividend - - 1.58 1.91
Dividend Yield (in %) 1.11 % 1.19 % 1.25 % 1.51 %
EPS 4.63 5.17 5.75 6.62
P/E Ratio 27.34 24.52 22.04 19.13
EBIT - 1,663 - 2,004
EBITDA 1,877 2,041 2,234 2,457
Net Profit 1,109 1,238 1,391 1,558
Net Profit Adjusted 1,129 1,258 1,391 1,558
Pre-Tax Profit 1,450 - - 2,010
Pre-Tax Profit Reported 1,203 1,483 1,670 -
EPS (Non-GAAP) ex. SOE 4.63 5.17 5.75 6.62
EPS (GAAP) 3.62 4.37 5.17 6.35
Gross Income 3,337 3,575 3,834 4,109
Cash Flow from Investing -282 -412 -427 -502
Cash Flow from Operations 1,222 1,572 1,767 2,117
Cash Flow from Financing -726 -716 -580 -394
Cash Flow per Share 5.13 6.22 6.91 -
Free Cash Flow 819 1,137 1,300 1,561
Free Cash Flow per Share 3.24 4.68 5.60 6.86
Book Value per Share 45.93 48.11 51.24 -
Net Debt 496 -116 -806 486
Research & Development Exp. 247 255 259 265
Capital Expenditure 380 410 424 453
Selling, General & Admin. Exp. 1,785 1,832 1,885 1,745
Shareholder’s Equity 11,286 11,856 12,495 14,043
Total Assets 16,991 17,571 18,243 19,791
  Previous Quarter
ending 03/31/25 		Current Quarter
ending 06/30/25 		Next Quarter
ending 09/30/25 		Current Year
ending 12/31/25 		Next Year
ending 12/31/26
Earnings Estimates
No. of Analysts - 17 17 19 19
Average Estimate - 1.144 USD 1.183 USD 4.633 USD 5.166 USD
Year Ago - 0.800 USD 0.893 USD 3.669 USD -
Publish Date - 8/5/2025 11/4/2025 - -
Revenue Estimates
No. of Analysts - 18 18 19 19
Average Estimate - 2,203 USD 2,175 USD 8,752 USD 9,172 USD
Year Ago - 2,169 USD 2,103 USD 8,563 USD -
Publish Date - 8/5/2025 11/4/2025 - -
* Average Estimates in Million (e.g. Revenue) or per share (e.g. Dividend). Source: FactSet

Income Statements in Mio. USD

2024 2023 2022 2021 2020 2019 2018
Sales 8,563.00 7,367.00 5,541.00 5,199.00 4,872.00 5,256.00 5,207.00
Change of sales in % 16.23 32.95 6.58 6.71 -7.31 0.94 10.76
Gross profit on sales 3,214.00 2,724.00 2,105.00 1,979.00 1,827.00 2,058.00 2,030.00
Gross profit on sales change in % 17.99 29.41 6.37 8.32 -11.22 1.38 9.97
Operating income 1,073.00 735.00 665.00 596.00 497.00 709.00 715.00
Operating income change in % 45.99 10.53 11.58 19.92 -29.90 -0.84 13.49
Income before tax 1,087.00 635.00 440.00 511.00 285.00 416.00 585.00
Income before tax change in % 71.18 44.32 -13.89 79.30 -31.49 -28.89 25.54
Income after tax 890.00 609.00 355.00 427.00 254.00 401.00 549.00
Income after tax change in % 46.14 71.55 -16.86 68.11 -36.66 -26.96 65.86

Balance Sheet in Mio. USD

2024 2023 2022 2021 2020 2019 2018
Total liabilities 5,611.00 5,936.00 4,449.00 5,050.00 5,774.00 4,743.00 4,440.00
Long-term liabilities per share 13.48 15.45 15.86 20.28 21.17 18.00 16.98
Equity 10,882.00 10,176.00 3,503.00 3,226.00 2,976.00 2,967.00 2,782.00
Equity change in % 4.68 190.96 8.58 8.42 0.37 6.83 10.59
Balance sheet total 16,493.00 16,112.00 7,952.00 8,276.00 8,750.00 7,710.00 7,222.00
Balance sheet total change in % 2.36 102.62 -3.91 -5.42 13.49 6.76 5.28

Key Data in USD

2024 2023 2022 2021 2020 2019 2018
Sales per share 35.16 33.77 30.62 28.64 26.90 29.01 28.75
P/E ratio (year end quote, basic EPS) 31.75 40.97 56.37 50.98 72.57 35.60 22.02
P/E ratio (year end quote, diluted EPS) 31.75 40.97 56.37 50.98 72.57 35.60 22.02
Dividend yield in % 1.24 1.15 1.09 0.93 1.02 1.22 1.26
Equity ratio in % 65.98 63.16 44.05 38.98 34.01 38.48 38.52
Debt ratio in % 34.02 36.84 55.95 61.02 65.99 61.52 61.48

Xylem Insider Activity

Name Date shares traded shares held Price type (sell/buy) option
Aulick Rodney 05/26/2025 1,665.00 74,304.00 126.24 Sell No
Harker Victoria D 05/12/2025 1,300.00 20,375.00 126.93 Buy No
FRIEL ROBERT F 05/12/2025 1,851.00 36,031.00 126.93 Buy No
Peribere Jerome A 05/12/2025 1,300.00 4,036.00 126.93 Buy No
Yadav Uday 05/12/2025 1,300.00 8,626.00 126.93 Buy No
Morelli Mark D 05/12/2025 1,300.00 6,298.00 126.93 Buy No
Tretikov Lila 05/12/2025 1,300.00 8,680.00 126.93 Buy No
Glatch Lisa 05/12/2025 1,300.00 10,064.00 126.93 Buy No
ELLIS EARL RAY 05/12/2025 1,300.00 4,309.00 126.93 Buy No
Pine Matthew Francis 03/10/2025 34,007.00 24,192.00 123.63 Sell No
Toussaint Claudia S 03/09/2025 6,197.00 3,939.00 129.78 Sell No
McShane Geri-Michelle 03/06/2025 4,119.00 3,950.00 128.18 Sell No
McShane Geri-Michelle 03/06/2025 3,119.00 8,069.00 80.66 Buy No
Pine Matthew Francis 03/04/2025 14,074.00 58,199.00 129.67 Buy No
Cho Albert 03/04/2025 1,060.00 13,970.00 129.67 Buy No
Grogan William K 03/04/2025 4,338.00 32,415.00 129.67 Buy No
Toussaint Claudia S 03/04/2025 2,024.00 10,136.00 129.67 Buy No
Capers Dorothy Trefon 03/04/2025 1,398.00 9,413.00 129.67 Buy No
Yarkadas Hayati 03/04/2025 2,314.00 19,616.00 129.67 Buy No
McGann Michael J. 03/04/2025 1,639.00 8,180.00 129.67 Buy No
McShane Geri-Michelle 03/04/2025 530.00 4,950.00 129.67 Buy No
Emmerich Meredith 03/04/2025 1,060.00 4,833.00 129.67 Buy No
Aulick Rodney 03/04/2025 1,639.00 75,774.00 129.67 Buy No
Capers Dorothy Trefon 03/03/2025 12,026.00 8,015.00 127.26 Sell No
Capers Dorothy Trefon 03/03/2025 4,158.00 20,041.00 101.09 Buy No

Xylem Dividend Calendar

Date Name Dividend *yield Currency
2024 Xylem Inc. 1.44 1.24 USD
2023 Xylem Inc. 1.32 1.15 USD
2022 Xylem Inc. 1.20 1.09 USD
2021 Xylem Inc. 1.12 0.93 USD
2020 Xylem Inc. 1.04 1.02 USD
2019 Xylem Inc. 0.96 1.22 USD
2018 Xylem Inc. 0.84 1.26 USD
2017 Xylem Inc. 0.72 1.06 USD
2016 Xylem Inc. 0.62 1.25 USD
2015 Xylem Inc. 0.56 1.54 USD
2014 Xylem Inc. 0.51 1.34 USD
2013 Xylem Inc. 0.47 1.35 USD
2012 Xylem Inc. 0.40 1.49 USD
2011 Xylem Inc. 0.10 0.39 USD
2010 Xylem Inc. - - USD
2009 Xylem Inc. - - USD
*Yield of the Respective Date

Xylem Calendar

Event Estimate Info Date
Earnings Report 1.144 USD Q2 2025 Earnings Release 08/05/2025
Earnings Report 1.183 USD Q3 2025 Earnings Release 11/04/2025
Earnings Report 1.300 USD Q4 2025 Earnings Release 02/10/2026
Earnings Report 1.109 USD Q1 2026 Earnings Release 05/05/2026

Xylem Past Events

Event Actual EPS Info Date
Annual General Meeting 3.650 USD Annual General Meeting 05/13/2025
Earnings Report 0.690 USD Q1 2025 Earnings Release 04/29/2025
Earnings Report 1.340 USD Q4 2024 Earnings Release 02/04/2025
Earnings Report 0.890 USD Q3 2024 Earnings Release 10/31/2024
Earnings Report 0.800 USD Q2 2024 Earnings Release 07/30/2024
Annual General Meeting 2.790 USD Annual General Meeting 05/16/2024
Earnings Report 0.630 USD Q1 2024 Earnings Release 05/02/2024
Earnings Report 1.100 USD Q4 2023 Earnings Release 02/06/2024
Earnings Report 0.630 USD Q3 2023 Earnings Release 10/31/2023
Earnings Report 0.450 USD Q2 2023 Earnings Release 08/02/2023
Annual General Meeting 1.960 USD Annual General Meeting 05/18/2023
Earnings Report 0.540 USD Q1 2023 Earnings Release 05/04/2023
Earnings Report 0.820 USD Q4 2022 Earnings Release 02/07/2023
Earnings Report 0.070 USD Q3 2022 Earnings Release 11/01/2022
Earnings Report 0.620 USD Q2 2022 Earnings Release 08/02/2022
Annual General Meeting 2.350 USD Annual General Meeting 05/12/2022
Earnings Report 0.450 USD Q1 2022 Earnings Release 05/04/2022
Earnings Report 0.620 USD Q4 2021 Earnings Release 02/03/2022

Xylem Profile

Xylem, Inc. engages in the design, manufacture, and application of engineered technologies for the water industry. It operates through the following business segments: Water Infrastructure, Applied Water, and Measurement and Control Solutions. The Water Infrastructure segment focuses on the transportation, treatment and testing of water. The Applied Water segment encompasses the uses of water and focuses on the commercial, residential, and industrial end markets. The Measurement and Control Solutions segment focuses on developing technology solutions that enable intelligent use and conservation of critical water and energy resources as well as analytical instrumentation used in the testing of water. The company was founded in 2011 and is headquartered in Washington, DC. .

Moody’s Daily Credit Risk Score

Risk
  • Low
  • Medium
  • High
4
Moody’s Daily Credit Risk Score is a 1-10 score of a company’s credit risk, based on an analysis of the firm’s balance sheet and inputs from the stock market. The score provides a forward-looking, one-year measure of credit risk, allowing investors to make better decisions and streamline their work ow. Updated daily, it takes into account day-to-day movements in market value compared to a company’s liability structure.

Xylem Management

Name Job
Geri McShane Chief Accounting Officer, VP & Controller
William K. Grogan Chief Financial Officer & Senior Vice President
David Flinton Chief Innovation, Technology & Product Management
Robert F. Friel Independent Chairman
Victoria Dux Harker Independent Director
Earl R. Ellis Independent Director
Uday Yadav Independent Director
Jerome A. Peribere Independent Director
Lila Alexey Tretikov Independent Director
Lisa Glatch Independent Director
Mark D. Morelli Independent Director
Keith Buettner Investor Relation Contact
Vincent Chirouze Managing Director-Middle East & North Africa
Matthew F. Pine President, Chief Executive Officer & Director
Christian Blanc SVP & President-European Commercial Operations
Albert H. Cho SVP, Chief Strategy & External Affairs Officer
Thomas F. Pettit SVP, Co-Chief Operations & Supply Chain Officer
Kelly C. O’Shea Secretary, Chief Corporate Counsel & VP
Hayati Yarkadas Senior VP & President-Water Infrastructure
Snehal A. Desai Senior VP, Chief Growth & Innovation Officer
Claudia S. Toussaint Senior VP, Chief People & Sustainability Officer